title: Alexion pays big for Synageva's rare disease drug candidate.
authors.forename: Mark
authors.initials: M
authors.lastname: Ratner
mesh_terms: D003237:Connecticut; D004345:Drug Industry / Q000191:economics*; D006801:Humans; D008404:Massachusetts; D065626:Non-alcoholic Fatty Liver Disease / Q000188:drug therapy*; D035583:Rare Diseases / Q000188:drug therapy; D002787:Sterol Esterase / Q000191:economics / Q000627:therapeutic use; D015223:Wolman Disease / Q000188:drug therapy
chemical_list: D002787:Sterol Esterase; C000603932:Sebelipase alfa